
Tuberculosis remains the second leading infectious killer worldwide. Extrapulmonary tuberculosis represents 15
The efficacy of bladder cancer treatment depends strongly on an accurate distinction between muscle-invasive and non-muscle-invasive disease. While the Vesical Imaging-Reporting and Data System (VI-RADS) provides a structured MRI-based assessment of detrusor muscle invasion, equivocal categories and interobserver variation may limit stand-alone decision-making. This study developed a diagnostic prediction model combining VI-RADS with TURBT-derived pathological grade for predicting muscle invasion in patients with bladder cancer. This retrospective study analyzed multiparametric magnetic resonance imaging (mpMRI) findings and clinical data from 152 patients with histologically confirmed bladder cancer treated between January 2018 and April 2024. Patients were classified as having muscle-invasive bladder cancer (MIBC) or non-muscle-invasive bladder cancer (NMIBC). Independent predictors of muscle invasion were identified using univariate and multivariate binary logistic regression analyses. Predictive performance and clinical utility were assessed using receiver operating characteristic (ROC) curves and decision curve analysis (DCA). The study was designed and reported in accordance with the TRIPOD guidelines for the development of prediction models. Of the 152 patients, 58 had MIBC and 94 had NMIBC. Multivariate logistic regression demonstrated that both pathological grade and VI-RADS score were independent predictors of muscle invasion. ROC curves identified a VI-RADS score ≥ 3 as the optimal threshold for predicting MIBC. The combination of pathological grade and VI-RADS score significantly improved diagnostic accuracy compared with either variable alone (p < 0.05) and provided greater net clinical benefit on DCA. The integration of pathological grade with VI-RADS scoring improves the preoperative assessment of muscle invasion in bladder cancer, enabling more accurate risk stratification and supporting informed clinical decision-making.
Precise prediction of perioperative outcomes for robot-assisted partial nephrectomy (RAPN), a cornerstone treatment for localized renal cell carcinoma (RCC), requires optimization. While the R.E.N.A.L. nephrometry score quantifies tumor anatomy and the Mayo Adhesive Probability (MAP) score assesses perinephric adhesion risk, their predictive efficacy remains debated. This study aimed to develop and validate a novel predictive model to guide RAPN clinical decision-making. A retrospective analysis was conducted on 704 patients undergoing primary RAPN for unilateral tumors at Nanjing Drum Tower Hospital between 2018 and 2023. Preoperative computed tomography (CT) and magnetic resonance imaging (MRI) images were evaluated in consensus by three physicians (two urologists and one radiologist), blinded to clinical outcomes, to obtain R.E.N.A.L. (Radius, Exophytic/endophytic, Nearness to collecting system, Location relative to polar lines) and MAP (Fat Thickness, Fat Stranding) parameters. The primary endpoint was Pentafecta achievement, defined as Trifecta (negative surgical margin, absence of Clavien-Dindo ≥ grade III complications, ≤ 30
To determine whether preoperative pelvic measurements obtained from multiparametric prostate magnetic resonance imaging are associated with vesicourethral anastomosis time and other perioperative outcomes after laparoscopic transperitoneal radical prostatectomy. This retrospective cohort included 112 patients treated from March 2021 to September 2024. Sixteen pelvimetric variables were measured on preoperative images. The primary outcome was anastomosis time; secondary outcomes were non-anastomotic operative time, estimated blood loss, and change in hemoglobin. Associations were examined using linear regression, with regression coefficients, 95